PlainRecalls
FDA Drug Moderate Class II Terminated

Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV

Reported: March 15, 2017 Initiated: January 19, 2017 #D-0492-2017

Product Description

Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV

Reason for Recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle

Details

Units Affected
37,445 bottles
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 37,445 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
Which agency issued this recall?
This recall was issued by the FDA Drug on March 15, 2017. Severity: Moderate. Recall number: D-0492-2017.